Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 25,151–25,175 of 27,380 studies, newest first · page 1007 of 1096.

June 2001 22

  1. 2001-06-01

    Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

    ✓ Peer-reviewed Vascular contributions Progress in neurobiology

    Key finding: In just under 20 years the kynurenine family of compounds has developed from a group of obscure metabolites of the essential amino acid tryptophan into a source of intensive research, with postulated roles for quinolinic acid in neurodegenerative disorders, most especially the AIDS-dementia complex and Huntington's disease. +3 more findings

  2. 2001-06-01

    Syndromic validity of apathy in Alzheimer's disease

    ✓ Peer-reviewed Vascular contributions The American journal of psychiatry

    Key finding: This study provides partial validation of specific clinical criteria for apathy in Alzheimer's disease. +1 more finding

  3. 2001-06-01

    Predictors of inadequate bowel preparation for colonoscopy

    ✓ Peer-reviewed Vascular contributions The American journal of gastroenterology

    Key finding: Several patient characteristics were significantly associated with colonic preparation quality independent of preparation type, compliance with preparation instructions, and procedure starting time. +3 more findings

  4. 2001-06-01

    Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia

    ✓ Peer-reviewed Clinical safety Acta neurologica Scandinavica

    Key finding: Behavioural characteristics accurately differentiate FTD from AD and CvD.

  5. 2001-06-01

    Prospective study of hallucinations and delusions in Parkinson's disease

    ✓ Peer-reviewed Clinical safety Journal of neurology, neurosurgery, and psychiatry

    Key finding: Visual hallucinations are common symptoms in Parkinson's disease and are most likely of multifactorial origin. +4 more findings

  6. 2001-06-01

    A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

    ✓ Peer-reviewed Cognitive tests and assessment Stroke

    We present a new ARWMC scale applicable to both CT and MRI that has almost equal sensitivity, except for certain regions.

  7. 2001-06-01

    Agitation in Demented Patients in an Acute Care Hospital: Prevalence, Disruptiveness, and Staff Burden

    ✓ Peer-reviewed Health systems and care delivery International Psychogeriatrics

    Key finding: Ninety-five percent of the patients with dementia were reported to have at least one agitated behavior; 75% had at least one moderately disruptive behavior. +4 more findings

  8. 2001-06-01

    CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts

    ✓ Peer-reviewed Inflammation and the immune system Neurology

    Key finding: Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) is a genetically heterogeneous disease characterized by a combination of systemic bone cysts and dementia. +3 more findings

  9. 2001-06-01

    Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

    ✓ Peer-reviewed Brain tissue and pathology Annals of neurology

    Key finding: We report a mutation at a novel site in APP in a three-generation Iowa family with autosomal dominant dementia beginning in the sixth or seventh decade of life. +3 more findings

  10. 2001-06-01

    Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia

    ✓ Peer-reviewed Cognitive tests and assessment Archives of gerontology and geriatrics

    Key finding: Therefore, 600 mg alpha-lipoic acid was given daily to nine patients with AD and related dementias (receiving a standard treatment with acetylcholinesterase inhibitors) in an open study over an observation period of, on avarage, 337+/-80 days. +2 more findings

  11. 2001-06-01

    The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of cell biology

    Key finding: Here, we report that APP and FE65 are involved in regulation of cell movement. +3 more findings

  12. 2001-06-01

    Chemistry and biochemistry of oxidative stress in neurodegenerative disease

    ✓ Peer-reviewed Lewy body dementia Current medicinal chemistry

    Key finding: Although several factors appear to underlie the pathological depositions, the cause of neuronal death in each disease appears to be multifactorial. +4 more findings

  13. 2001-06-01

    Allele varepsilon4 of apolipoprotein E gene is less frequent in Down syndrome patient of the Sicilian population and has no influence on the grade of mental retardation

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuroscience letters

    Key finding: Allele varepsilon4 and varepsilon3 frequencies were respectively lower (P=0.015) and higher (P=0.005) in DS patients compared to controls. +1 more finding

  14. 2001-06-01

    Evidence for apoptosis in the fetal Down syndrome brain

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of child neurology

    Key finding: Various apoptosis-associated proteins (Bax, Bcl-2, Fas, p53, Hsp70, neuronal apoptosis inhibitory protein-like immunoreactivity) were investigated in four different cortical regions and the cerebellum of one fetal Down syndrome (35 weeks' gestation) postmortem brain sample compared with a control brain sample. +1 more finding

  15. 2001-06-01

    Brain t-complex polypeptide 1 (TCP- 1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Life sciences

    Key finding: When t-complex polypeptide I was related to its natural and specific substrate beta 1 tubulin, the ratio was significantly decreased in the temporal, frontal, parietal cortex and in thalamus of patients with Alzheimer's disease. +1 more finding

  16. 2001-06-01

    Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization

    ✓ Peer-reviewed How common it is JAMA

    Key finding: Our prognostic index, which used 6 risk factors known at discharge and a simple additive point system to stratify medical patients 70 years or older according to 1-year mortality after hospitalization, had good discrimination and calibration and generalized well in an independent sample of patients at a different site. +1 more finding

  17. 2001-06-01
  18. 2001-06-01
  19. 2001-06-01
  20. 2001-06-01

    Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada

    ✓ Peer-reviewed Prevention and risk International journal of epidemiology

    Key finding: Some well-known risk factors for AD were confirmed in this study and potential new risk factors were identified. +2 more findings

  21. 2001-06-01

    Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults

    ✓ Peer-reviewed Genetics JAMA

    Key finding: A significant portion of sleep-disordered breathing is associated with ApoE epsilon4 in the general population. +3 more findings

  22. 2001-06-01

    Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

    Key finding: Changes in the metabolic activity within the brain of patients suffering from Alzheimer's disease (AD) were investigated and compared with biochemical alterations in the hippocampus induced by fimbria/fornix transection in the rat. +4 more findings

May 2001 3

  1. 2001-05-01

    The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Life sciences

    Key finding: Complex I 24-kDa subunit was significantly reduced in occipital cortex and thalamus in patients with DS and temporal and occipital cortices in patients with AD. +2 more findings

  2. 2001-05-01

    Neurologists' use of ICD-9CM codes for dementia

    ✓ Peer-reviewed Digital health tools Neurology

    Key finding: Other codes used were not inaccurate but would result in lower reimbursement.

  3. 2001-05-01

Browse the library by subject, with the full score breakdown →